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Strongest models were faecal HILIC (R2X  =  0.129, R2Y  =  0.8, 
Q2Y  =  0.596, p = 6.47  ×  10−5) and urine HILIC (R2X  =  0.164, 
R2Y = 0.783, Q2Y = 0.526, p = 7.11 × 10−12). Urinary NMRS showed 
higher isobutyrate, lactate and alanine in the SA group whilst hip-
purate, 4-cresol sulphate, lysine and citrate were reduced. Secondary 
bile acids (5B-cholanic acid-3a, 6a-diol-7-one) were higher in 
the SA group and four secondary bile acids (3-Ketocholanic acid, 
Lithocholic acid, Isolithocholic acid, 3a-hydroxy-12-ketolithocholic 
acid) were lower. There were no discriminatory features identified 
during time point and treatment subgroup analysis.
Conclusions: This prospective, longitudinal inception cohort study 
demonstrates significant differences driven by ethnicity despite simi-
lar diet. SA had more severe disease which maybe a confounding fac-
tor. Analysis of paired samples pre- and post-remission are required. 
Further studies employing metagenomics techniques may define pro-
inflammatory pathways specific to SA and justify different treatment 
approaches.
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Background: Crohn disease (CD) affects predominantly the ileum 
and/or the colon. Previous genome wide association studies have 
revealed that patients with ileal or colonic disease present partly dis-
tinct risk loci. This finding opens new perspectives for the develop-
ment of personalised treatments and biomarkers based on disease 
location. To this end, protein-based approaches are needed to dis-
cover new tissue-specific proteins associated with CD. The goal of 
our study was to decipher the relation linking disease location and 
physiopathological processes by comparing the proteomic picture of 
ileal/colonic CD ulcers with normal tissues.
Methods: CD patients (n = 16)  with ileum (n = 8)  or colon 
(n = 8) ulcers were included. Paired biopsies were taken at the edges 
of the ulcer (U) and in the nearby endoscopically normal mucosa 
(N). Label free proteomic differential analysis was run using pro-
tein digests obtained with the 16 paired biopsies. Identifications and 
quantification of proteins were performed using MaxQuant. Paired 
t-test with Benjamini–Hochberg correction was applied for selec-
tion of proteins differentially abundant between N and U tissues. 
Pathway enrichment analysis was performed with the Database for 
Annotation, Visualization and Integrated Discovery (DAVID) bioin-
formatics tool.
Results: We identified and quantified 4652 and 5422 proteins in 
ileum and colon samples, respectively. Among these proteins, 440 
(ileum) and 409 (colon) were differentially distributed between 
N and U tissues. The well-recognised fecal marker of CD activ-
ity, calprotectin, was increased in U, showing consistency of our 
results with clinical observations. When proteins where ranked by 
increasing p-value, the calprotectin subunits S100-A9 and S100-A8 
appeared respectively at the 266–300th (ileum) and the 142–165th 
(colon) positions, suggesting that our dataset could reveal new rele-
vant proteins in CD. In both ileum and colon ulcers, pathway enrich-
ment analysis showed that the proteins decreased in lesions, were 
related to energetic metabolism, whereas the increased ones were 
mainly involved in the endoplasmic reticulum-Golgi protein pro-
cessing and the immune response. In the ileum, the over-abundant 
proteins found in U were also involved in mRNA maturation and 
protein translation, this was not observed in the colon.
Conclusions: Our proteomic experiment highlights common and 
distinct physiopathological processes between ileal and colonic CD 
ulcers, thus indicating a partial segment specificity of the disease. 
Further investigations are required to confirm these results. Among 
the 849 proteins differentially abundant between N and U mucosa, 
new therapeutic targets and new biomarkers could emerge for CD 
patient management.
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Background: Development of anti-adhesion therapies like 
Etrolizumab and Alicaforsen highlights the potential for inhib-
iting recruitment pathways in ulcerative colitis (UC). Recent 
in vitro mouse work from our group shows that disruption of 
Phosphodiesterase (PDE) 8A domains inhibits T cell adhesion to 
ICAM-1 and endothelial cells.1 PDE inhibitors are known immuno-
suppressive agents, yet no PDE inhibitors are approved in UC due 
to dose-limiting side effects. As PDE8A is the most efficient in vivo 
hydrolyser of cAMP, PDE8A inhibitors are good candidates for 
overcoming the challenges presented mainly by PDE4 inhibitors. 
PDE8A expression in colorectal cancer (CRC) is well documented 
and PDE8A is reported in UC intestinal crypts by gene and protein 
array. However, the in situ localisation of PDE8A in UC submu-
cosa during recruitment of leukocytes is unknown. Therefore, we 
developed an image analysis method to highlight PDE8A domains 
and investigated whether PDE8A domains were present at the site 
of leucocyte-endothelial cell adhesion in the submucosa of inflamed 
UC resections.
Methods: PDE8A protein expression in five involved and two unin-
volved UC colon resections was determined by immunohistochem-
istry using anti-PDE8A (ab61815) or IgG isotype (ab125938). Six 
paired biopsies from CRC (involved and uninvolved) were used as 
controls. Antibodies were titrated to 1:250 to reveal subcellular 
domains masked by diffuse staining at 1:100. Images were ana-
lysed using the saturation feature (0-255) in Image J software to 
assign PDE8A staining intensity as a representation of subcellular 
domains (Figure A).
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